Unique challenges in clinical trials in traumatic brain injury.
about
Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis?Animal models of traumatic brain injuryAnimal models of traumatic brain injuryEnvironmental enrichment promotes robust functional and histological benefits in female rats after controlled cortical impact injuryPre-Clinical Traumatic Brain Injury Common Data Elements: Toward a Common Language Across Laboratories.Reliability of the NINDS common data elements cranial tomography (CT) rating variables for traumatic brain injury (TBI).Age-dependent regional mechanical properties of the rat hippocampus and cortex.Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patientsNeurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.Antioxidant therapies in traumatic brain and spinal cord injuryEvaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury.The neuroethics and neurolaw of brain injury.Death following traumatic brain injury in Drosophila is associated with intestinal barrier dysfunction.Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.A Method to Inflict Closed Head Traumatic Brain Injury in DrosophilaEvaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.Donepezil is ineffective in promoting motor and cognitive benefits after controlled cortical impact injury in male ratsStatins in traumatic brain injury.Diffuse traumatic brain injury and the sensory brain.The contribution of astrocytes and microglia to traumatic brain injuryAlternative clinical trial design in neurocritical care.5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Clinical Outcomes after Traumatic Brain Injury.Challenges Enrolling Children Into Traumatic Brain Injury Trials: An Observational Study.Abbreviated environmental enrichment confers neurobehavioral, cognitive, and histological benefits in brain-injured female rats.The Therapeutic Efficacy of Environmental Enrichment and Methylphenidate Alone and in Combination after Controlled Cortical Impact Injury.Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injuryTreatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.Exploring new routes for neuroprotective drug development in traumatic brain injury.Low-Molecular-Weight Fucoidan Attenuates Mitochondrial Dysfunction and Improves Neurological Outcome After Traumatic Brain Injury in Aged Mice: Involvement of Sirt3.Rehabilitative Success After Brain Trauma by Augmenting a Subtherapeutic Dose of Environmental Enrichment With Galantamine.Refining environmental enrichment to advance rehabilitation based research after experimental traumatic brain injury.Dynamic, regional mechanical properties of the porcine brain: indentation in the coronal plane.Research priorities in neurocritical care.Cerebral microhemorrhages due to traumatic brain injury and their effects on the aging human brain.Predicting long-term global outcome after traumatic brain injury (TBI): Development of a practical prognostic tool using the TBI Model Systems National Database.
P2860
Q26827953-DB857242-FE44-4B6F-83FC-18021A482869Q27025091-622EBB68-E359-4113-BC3A-CF926A18D868Q27025951-C0548E8E-E159-40E1-B089-A2AC98770192Q28397697-E5B680DB-6B86-40B6-A41D-8B7F63416FADQ30968544-034FADBC-662E-4E88-A524-B9A8D8DBB1CBQ31147998-B1891471-A2DB-48A1-8606-85C570636110Q33594740-F394A947-648A-4F99-9CBD-B38F44012113Q33641789-B05F484C-A8AA-45EB-B481-3039A4D37F43Q34043822-A2CB0031-12EC-422C-8E17-274D8B8062DCQ34049949-968E9679-6A9D-4476-823C-7A7626C82AF7Q34296853-AAC1B329-156C-4233-9D1A-80DB4AE79EB3Q34377539-B982F9D7-C698-4A5C-8BE2-D5D3E668AA55Q35227177-61C7C838-23BC-4EC3-9836-405A4E529568Q35589949-3665B218-DAB5-497C-AA46-E667A4B4CBACQ35842329-835DF455-179B-4EDB-8984-F328ECD30601Q35982760-5C9F0A54-26F4-4784-A27F-339875128B1CQ36079887-515E2F7C-C926-4F5F-9652-B82DE5AF5EA3Q36795887-123A70AE-E563-4EFB-BB08-456449B840E3Q37374151-4C2F9D47-190B-43B1-BEC9-2E1A71B762B7Q38101157-FB6B6281-E7E5-4674-9882-8DF0EF668995Q38263517-49299BA3-B27A-462C-8F35-33CE17034005Q38430484-29BB215B-2E89-4310-AAA1-BEE9F9B3CCBCQ38650071-87948D58-CAAE-4657-930D-D1506535D4B0Q38807028-69914136-8996-4C32-9E6F-14B392DF8FB0Q38822222-5ED33EBD-5EBD-4D4C-940A-00E6AC63003CQ39331725-50D91D44-5B4A-40DD-9922-A2439B8B9EDEQ39923810-CF54E535-24A3-4F32-8868-0D05B06A3EB2Q41945099-758071BC-4DC2-4034-81E7-3203A5A7FC81Q42365639-70418007-75B9-4DDC-9024-015CE4BDCDA6Q42775909-680EF55F-4925-4C7C-AAC9-761B025F52E6Q46152263-581C3735-14F5-4A41-9A8E-FDCC1CD95349Q46613741-2DCADE0D-B237-4E12-BDCF-ED1B11CA018AQ47799933-C03D5B45-781B-41C1-9BAE-FD63E5565682Q47891032-FE113E64-A573-4480-8690-39D03A3F946EQ48959260-9311A7AD-A624-46BC-824B-0538414478A2Q51018816-5B2EA825-2B0D-4DF6-8F38-88207731045DQ51759418-7E7910FE-7010-4E97-B8E8-1A68D0E7421CQ52642446-15A23513-358E-4681-B71A-BFE2F58576A4
P2860
Unique challenges in clinical trials in traumatic brain injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unique challenges in clinical trials in traumatic brain injury.
@en
Unique challenges in clinical trials in traumatic brain injury.
@nl
type
label
Unique challenges in clinical trials in traumatic brain injury.
@en
Unique challenges in clinical trials in traumatic brain injury.
@nl
prefLabel
Unique challenges in clinical trials in traumatic brain injury.
@en
Unique challenges in clinical trials in traumatic brain injury.
@nl
P1476
Unique challenges in clinical trials in traumatic brain injury.
@en
P2093
David K Menon
P304
P356
10.1097/CCM.0B013E3181921225
P407
P433
P577
2009-01-01T00:00:00Z